Differential post-translational modification of CD63 moleculesduring maturation of human dendritic cells Anneke Engering1,3, Lotte Kuhn1,2, Donna Fluitsma3, Elisabeth Hoefsmit3and Jean P
Trang 1Differential post-translational modification of CD63 molecules
during maturation of human dendritic cells
Anneke Engering1,3, Lotte Kuhn1,2, Donna Fluitsma3, Elisabeth Hoefsmit3and Jean Pieters1,2
1
Basel Institute for Immunology, Basel, Switzerland;2Biozentrum, University of Basel, Basel, Switzerland;
3
Department of Cell Biology and Immunology, Vrije Universiteit, Amsterdam, The Netherlands
The capacity of dendritic cells to initiate T cell responses is
related to their ability to redistribute MHC class II
mole-cules from the intracellular MHC class II compartments to
the cell surface This redistribution occurs during dendritic
cell development as they are converted from an antigen
capturing, immature dendritic cell into an MHC class
II-peptide presenting mature dendritic cell During this
matu-ration, antigen uptake and processing are down-regulated
and peptide-loaded class II complexes become expressed in
a stable manner on the cell surface Here we report that
the tetraspanin CD63, that associates with intracellularly
localized MHC class II molecules in immature dendritic
cells, was modified post-translationally by poly N-acetyl lactosamine addition during maturation This modification
of CD63 was accompanied by a change in morphology of MHC class II compartments from typical multivesicular organelles to structures containing densely packed lipid moieties Post-translational modification of CD63 may be involved in the functional and morphological changes of MHC class II compartments that occur during dendritic cell maturation
Keywords: antigen presentation; poly N-acetyl lactosamine addition; dendritic cells; tetraspanins; MHC class II
Dendritic cells have the unique feature to induce T cell
responses in lymphoid organs against antigens captured in
peripheral tissues (for review, see [1,2]) Immature tissue
dendritic cells use several mechanisms to internalize a broad
array of antigens via the endosomal–lysosomal pathway
including fluid phase endocytosis, macropinocytosis and
several receptor-dependent mechanisms [3–5] Peptides
derived from internalized antigens are loaded onto class II
molecules in MHC class II compartments [6–9] After
migration to lymph nodes upon inflammation or an
infection, mature dendritic cells present these MHC
class II-peptide complexes to T lymphocytes
Several co-ordinated changes enable efficient
presenta-tion of epitopes generated at sites of inflammapresenta-tion to
T lymphocytes for prolonged periods of time [10,11]
During maturation of dendritic cells, the number of MHC
class II-peptide complexes that are generated is increased,
both by a transient up-regulation of synthesis as well as by
an increase in half-life of MHC class II molecules [10] In
addition, uptake and processing of antigen is
down-regulated and MHC class II molecules are redistributed to
the cell surface Trafficking of MHC class II-peptide
com-plexes is in part regulated by the protease, cathepsin S, that
is activated upon maturation of dendritic cells [12,13] This protease removes the sorting signal in the cytoplasmic tail of the invariant chain, a protein involved in targeting newly synthesized MHC class II molecules to MHC class II com-partments [14–16], thus allowing MHC class II molecules
to exit these organelles Moreover, maturation induces a reduction of internalization and degradation of cell surface MHC class II molecules [17] These mechanisms result in the stable expression of MHC class II-peptide complexes
on the cell surface of mature dendritic cells [10,11,18] Recently, more insight has been gained into the transport-routes of MHC class II molecules to the plasma membrane [19,20] Direct fusion of multivesicular MHC class II compartments has been shown to occur, resulting in secretion of the internal MHC class II-con-taining vesicles, so-called exosomes [21,22] However, this route is down-regulated upon maturation of dendritic cells and may represent only a minor pathway of MHC class II transport to the cell surface [22,23] Recently, using GFP-tagged MHC class II molecules in living murine dendritic cells, it was shown that upon a maturation stimulus, tubular MHC class II-containing endosomes extend from MHC class II compartments and can fuse directly with the plasma membrane [24,25] Interestingly, these tubules were directed towards the contact phase with a T cell in
an antigen-dependent manner [24] In human dendritic cells, immuno-electron microscopy also demonstrated the appearance of MHC class II-containing tubules and vesi-cles upon induction of maturation [26] These structures were suggested to represent transport intermediates between MHC class II compartments and the plasma membrane [26,27] The underlying mechanisms of trans-porting MHC class II-containing vesicles to the cell surface remain unclear
Correspondence to J Pieters, Biozentrum, University of Basel,
Klingelbergstrasse 50–70, 4056 CH Basel, Switzerland.
Fax: + 41 61 267 21 49, Tel.: + 41 61 267 21 51,
E-mail: jean.pieters@unibas.ch
Abbreviations: CD, cluster of differentiation; endo H,
endoglyco-sidase H; LAMP, lysosomal-associated membrane proteins; LPS,
lipopolysaccharide; MHC, major histocompatibility complex.
(Received 18 February 2003, accepted 7 April 2003)
Trang 2associate with MHC class II molecules at different sites in
immature dendritic cells [28] CD9, CD53 and CD81
associate with surface MHC class II molecules, whereas
CD63-MHC class II complexes are present exclusively in
MHC class II compartments Similarly, in B cells, CD63 as
well as the tetraspanin CD82 were shown to associate with
MHC class II molecules intracellularly [29] In this paper,
we describe that CD63 is modified post-translationally upon
maturation of dendritic cells This modification was
attri-buted to the addition of poly N-acetyl lactosamine groups
onto CD63 Interestingly, CD63-positive organelles
chan-ged morphologically during dendritic cell maturation –
from compartments with a multilaminar appearance into
structures containing multiple condensed lipid layers The
increase in lactosaminoglycans on CD63 may be involved
in the changes that occur in MHC class II compartments
during dendritic cell maturation
Materials and methods
Antibodies, reagents and cells
The following antibodies were used: I98 (anti-CD63, IgG1),
anti-CD63 (IgG1, CLB, Amsterdam), and a polyclonal
antibody against MHC class II (kind gift of H Ploegh,
Harvard Medical School, Boston, MA, USA)
Dendritic cells were generated from human peripheral
blood monocytes cultured for 4–8 days in RPMI-1640
medium supplemented with 10% fetal bovine serum
(Hyclone), 50 ngÆmL)1recombinant GM-CSF (Leucomax,
Sandoz) and 1000 UÆmL)1recombinant IL-4 [4,30] Buffy
coats were from healthy blood donors, upon written
consent To induce maturation, dendritic cells were
stimu-lated with LPS for 40 h (1 lgÆmL)1, S abortus equi, Sebak)
The human melanoma cell line, Mel JuSo [31] was grown in
RPMI-1640 supplemented with 10% fetal bovine serum;
cells were stimulated by culturing for 48 h in 500 UÆmL)1
Interferon-c (IFN-c) (Pharmingen)
Metabolic labeling and immunoprecipitation
Prior to metabolic labeling, cells were cultured in RPMI
without methionine and cysteine for 20 min Cells were
labeled for the times indicated in the same medium
containing 0.1–0.2 mCiÆmL)1[35S]methionine/cysteine and
10% dialyzed fetal bovine serum Cells were washed and
chased in complete medium, supplemented with 2 mM
methionine and cysteine, or lysed directly Lysis buffer
contained 20 mMHepes (pH 7.5) with 100 mMNaCl, 5 mM
MgCl2, 1% Triton X-100 with protease inhibitors [32]
For immunoprecipitation, lysates were incubated with
the indicated antibodies for 2–12 h at 4°C, followed by 1 h
incubation with 30 lL protein A-Sepharose (Pharmacia)
The immune complexes were washed as described [33],
eluted from the protein A-Sepharose beads by incubation at
95°C for 5 min in Laemmli sample buffer [34] and
subjected to SDS/PAGE, fluorography and
autoradio-graphy When indicated, half of the immune complexes
were incubated prior to elution with 10 mU
endo-b-galactosidase (Bacteroides fragilis, Boehringer Mannheim)
in 50 m sodium acetate (pH 5.8) with 0.2 mgÆmL)1bovine
was omitted
Two-dimensional gel electrophoresis Two-dimensional IEF/SDS/PAGE was performed accord-ing to O’Farrell [35] with described modifications [36] Resolyte pH 4–8 (BDH) was used for IEF
Immunocytochemistry Dendritic cells were fixed at room temperature in 2% paraformaldehyde and 0.5% glutaraldehyde in NaCl/Pifor
2 h Cells were pelleted and resuspended in 2% para-formaldehyde at 4°C Subsequently, samples were infused with 2.3M sucrose and frozen quickly in liquid nitrogen Ultrathin cryosections were labeled with specific primary antibodies as indicated, followed by colloidal gold particles coupled to protein A To minimize cross reactivity of protein A-gold particles, sections were fixed briefly using 1% glutaraldehyde before double-labeling Cryosections were analyzed on a CM 100 electron microscope (Philips) Subcellular fractionation
Subcellular fractionation of dendritic cells was performed essentially as described [4,7,37] Dendritic cells were harves-ted, washed and resuspended in homogenization buffer (10 mMtriethanolamine, 10 mMacetic acid, 1 mMEDTA, 0.25M sucrose, pH 7.4) at 107cellsÆmL)1 The cells were homogenized at 4°C by passing through a 27G3/4 needle After removal of the nuclei by centrifugation (840 g,
15 min), the postnuclear supernatant was incubated with trypsin (25 lgÆmg)1protein) for 5 min at 37°C Digestion was stopped by addition of ice-cold soybean trypsin inhibitor (625 lgÆmg)1protein) Membranes were
sediment-ed by centrifugation for 45 min at 100 000 g, resuspendsediment-ed
in 6% Ficoll-70 (Pharmacia) in homogenization buffer and electrophoresed for 90 min at 10.4 mA [7] Fractions of 0.5 mL were collected from the top and analyzed for the different markers Protein levels were analyzed according to the Bradford method [38] The activity of b-hexosaminidase was assayed as described [39]
Results
Analysis of CD63 expression during dendritic cell maturation
Upon maturation, dendritic cells undergo a number of changes that contribute to their capacity to induce T cell responses [10,11,24–26] These changes include biochemical
as well as morphological alterations in organelles and molecules involved in MHC class II-restricted T cell activation The tetraspanin CD63 associates with MHC class II molecules within class II compartments in a number of antigen presenting cells [29,40], including human immature dendritic cells [28] To analyze CD63 expression during maturation, immature and mature dendritic cells were pulse-labeled with [35S]methionine/cysteine, and CD63 molecules immunoprecipitated and analyzed by SDS/ PAGE and fluorography After a 20-min labeling period,
Trang 3in both immature and mature dendritic cells, a protein of
34 kDa was resolved (Fig 1A, lane 1 and 3) However, after
a 4-h pulse, in immature dendritic cells, anti-CD63 Igs
immunoprecipitated alongside the 34 kDa polypeptide, an
50 kDa protein, the molecular mass of which increased
to 70 kDa after maturation of the cells induced by LPS
(Fig 1A, lane 2 and 4) The increase in molecular mass of
CD63 was independent of the stimulus used to induce
maturation of dendritic cells (not shown) In all other cell
types tested (including B lymphoblastoid, HeLa, Mel JuSo
cells, with or without stimulation by LPS or IFN-c) CD 63
antibodies precipitated a 34 and 50 kDa protein (shown for
Mel JuSo, Fig 1A, lanes 5–8) This indicates that the
34 kDa protein of CD63 either became associated with
distinct proteins during maturation, or that CD63 was
differentially modified post-translationally in immature vs
mature dendritic cells
To distinguish between these two possibilities, pulse/chase
analysis was performed As shown in Fig 1B, in both
immature and mature dendritic cells, the amount of the
34 kDa form of CD63 disappeared gradually during the
chase period, concomitantly with the appearance of isoforms
of CD63 of 50 and 70 kDa, respectively Together, these
data indicate that the 70 kDa isoform of CD63 is a result of
post-translational modifications of the 34 kDa isoform
that occurred exclusively in mature dendritic cells
Characterization of post-translational modifications
on CD63 during maturation of dendritic cells
CD63 contains three putative acceptor sites for N-linked
glycosylation [41] To analyze the addition of carbohydrates
to these sites in CD63 molecules from immature and mature
dendritic cells, both cell types were labeled for 10 min
with [35S]methionine and -cysteine, lysed and proteins were precipitated using anti-CD63 Igs Immuno-isolated com-plexes were treated with endoglycosidase H (endo H) This enzyme cleaves N-linked glycans of the high mannose form that are acquired upon synthesis in the endoplasmic reticulum As shown in Fig 2A, endo H treatment resulted
in a reduction of the apparent molecular mass to 25 kDa
in immature as well as in mature dendritic cells, indicating identical N-linked glycosylation of CD63 in immature as well as mature dendritic cells
To analyze the type of modification on CD63 occurring during maturation, immature and mature dendritic cells were labeled metabolically for 16 h and immunoprecipi-tated material analyzed by two-dimensional IEF/SDS/ PAGE followed by fluorography In immature cells, besides the 34 kDa form of CD63, eight additional spots of
50 kDa were resolved The shapes of these spots indicated that they represent forms of CD63 that have been modified post-translationally with carbohydrate residues Interest-ingly, after maturation of dendritic cells, the apparent molecular mass of each of these eight carbohydrate containing polypeptides was increased by 10 kDa (Fig 2B) In mature dendritic cells, the 34 kDa form of CD63 was not detectable anymore, indicating a more complete conversion of CD63 to the complex-type carbo-hydrate form than in immature dendritic cells during the
16 h labeling period Together, these results indicate that not only the type or complexity, but the degree of CD63 glycosylation differed in immature vs mature dendritic cells
A modification known to result in differences in mole-cular mass, rather than charge, is addition of poly N-acetyl lactosamine to N-linked glycans, and this post-translational modification is known to occur on lysosomal associated membrane glycoproteins (LAMP) [42,43] Poly
γ
Fig 1 CD63 isoforms in immature and mature dendritic cells (A) Immature dendritic cells, mature dendritic cells (DC) and Mel JuSo cells incubated for 48 h in the absence or presence of IFN-c were labeled metabolically for 20 min or 4 h using [ 35 S]methionine/cysteine and lysed Proteins were immunoprecipitated with anti-CD63 Igs (B) Immature and mature dendritic cells were labeled metabolically for 10 min, washed and cultured for the times indicated before lysis and immunoprecipitation with anti-CD63 Shown are autoradiographs after SDS/PAGE and fluorography.
Trang 4N-lactosamine groups are sensitive to endo-b-galactosidase
[43] To analyze the presence of polylactosaminoglycans,
immature dendritic cells and maturing cells, cultured for
12 h in the presence of LPS, were labeled metabolically for
4 h, followed by lysis and immunoprecipitation using
anti-CD63 or anti-LAMP Igs Immune complexes were
incuba-ted for 24 h at 37°C in the presence or absence of 10 mU
endo-b-galactosidase As can be seen in Fig 3A and B in
both immature and maturing dendritic cells, CD63 as well
as LAMP molecules are susceptible to digestion with
endo-b-galactosidase Therefore, these results indicate that
poly-lactosaminoglycan addition already occurs in immature
cells, and that during maturation these molecules acquire
additional polylactosaminoglycans Indeed, when immature
dendritic cells were induced to mature by LPS, a gradual
increase in the molecular masss of both CD63 and LAMP
was observed, reaching a maximum after 12–24 h, with a
subsequent decrease of the apparent molecular mass
(Figs 3C,D) As can be seen in Fig 3C,D, both the
biosynthesis and the polylactosaminoglycan addition is
dependent on the state of maturation, as has also been
observed to occur for other molecules during maturation
[10]
Stability and subcellular localization of CD63 molecules
in immature and mature dendritic cells
Maturation of dendritic cells is known to result in a
differential stability of MHC class II [10,11] Given the
association of CD63 molecules with MHC class II
mole-cules in MHC class II compartments [28,29], we analyzed
whether the addition of polylactosaminoglycan moieties on
CD63 molecules resulted in an altered stability of CD63 To
that end, immature and mature dendritic cells were pulsed
for 1 h with [35S]methionine/cysteine followed by a chase for
the times indicated in Fig 4 As shown in Fig 4, both in
immature as well as mature dendritic cells, CD63 molecules displayed a similar half life of 15 h, indicating that the degree of polylactosaminoglycan modification does not alter CD63 stability
In immature dendritic cells, CD63 is largely located intracellularly within MHC class II compartments [28,29,40] To investigate whether the post-translational modification of CD63 molecules by polylactosaminoglycans may coincide with an altered subcellular localization, organelles from [35S]methionine/cysteine metabolically labe-led immature as well as mature dendritic cells were separated by organelle electrophoresis Upon electropho-resis, MHC class II compartments and late endosomal lysosomal organelles shift towards the anode, whereas the plasma membrane and most other subcellular organelles
do not migrate significantly [4,7] After fractionation, the fractions containing the lysosomal marker b-hexosamini-dase were pooled (Pool I) as well as the nonshifted fractions (Pool II; see Fig 5A) From these pooled fractions, CD63
as well as LAMP molecules were immunoprecipitated and analyzed by SDS/PAGE and fluorography As shown in Fig 5B in both immature and mature dendritic cells, CD63
as well as LAMP were largely present within pool I, indicating that before and after maturation of den-dritic cells, CD63 remained localized within MHC class II compartments
Immunocytochemical localization of CD63 in immature and mature dendritic cells
The subcellular distribution of CD63 molecules was analyzed further by immunocytochemistry using immature and mature dendritic cells In immature dendritic cells, CD63 colocalized with class II molecules in MHC class II compartments, predominantly with a multilaminar appear-ance (Fig 6Aa) CD63 was occasionally detected in small
Fig 2 Two dimensional gel electrophoresis of CD63 isoforms (A) Core-glycosylation of CD63 molecules Immature (imm DC) and mature dendritic cells (mat DC) were labeled metabolically with [ 35 S]methionine/cysteine for 10 min and lysed Immune-isolated complexes after preci-pitation with anti-CD63 Igs were incubated with (+) or without (–) endo-glycosidase H (endo H) for 14 h at 37 °C An asterix indicates the deglycosylated forms of CD63 (B) Immature and mature dendritic cells were labeled with [35S]methionine/cysteine for 14 h After lysis, proteins were immunoprecipitated with anti-CD63 Igs and analyzed by IEF/SDS/PAGE Shown are autoradiographs after SDS/PAGE and fluorography, basic end, right; acidic end, left.
Trang 5electron dense vesicles, devoid of MHC class II molecules
(Figs 6Aa,c), potentially representing a transport vesicle
After maturation, MHC class II molecules are redistributed
to the cell surface, whereas CD63 was still predominantly found intracellularly (Figs 6Bb,d) Interestingly, the mor-phology of CD63 positive organelles changed upon matur-ation from the typical multilaminar structure into an organelle that appeared to contain densely packed lipid moieties (Fig 6A) This difference in morphology is further illustrated in Fig 6B, that shows several sections labeled for MHC class II molecules In mature dendritic cells, densely packed structures were abundantly present (Figs 6Bb–d) but were rarely found in immature dendritic cells (Fig 6Ba) Taken together, these results indicate that concomitant with the acquisition of polylactosaminoglycans on CD63, the MHC class II compartments became altered, both with respect to their morphology as well as the occupancy
Discussion
Dendritic cells efficiently present epitopes from antigens captured at sites of inflammation to naive T lymphocytes in lymphoid organs by regulating MHC class II distribution and antigen-internalization mechanisms [1–3,18] In imma-ture dendritic cells, antigens are efficiently internalized and antigenic peptides loaded onto MHC class II complexes intracellularly [44] Maturation stimuli induce a transient enhancement of antigen uptake and peptide loading, whereas in fully matured dendritic cells, antigen uptake is down-regulated and peptide-loaded class II complexes are redistributed to the cell surface [10,11,44] The molecular mechanisms regulating these processes are not well under-stood In this paper, we describe that during maturation
of dendritic cells, CD63 acquired additional polylactos-aminoglycans, concomitant with morphological changes
β
Fig 3 CD63 and LAMP glycosylation in immature and mature dendritic cells Poly N-acetyl lactosaminoglycans on CD63 and LAMP molecules during maturation of dendritic cells (A,B): Dendritic cells were incubated with LPS for the times indicated, followed by metabolic labeling with [ 35 S]methionine/cysteine for 4 h Cell lysates were immunoprecipitated with anti-CD63 (A,C) or anti-LAMP (B,D) Igs In A and B, immuno-isolated complexes were incubated in the presence (+) or absence (–) of endo-b-galactosidase (endo-b) for 24 h at 37 °C The differences in metabolic labeling are probably to be due to the different efficiencies in labeling at the different times after LPS addition Shown are autoradio-graphs after SDS/PAGE (A,C: 12% acrylamide gels; B,D: 7.5% acrylamide gels) and fluorography.
Fig 4 Stability of CD63 molecules in immature and mature dendritic
cells Immature and mature dendritic cells were labeled metabolically
with [ 35 S]methionine/cysteine followed be a chase in normal medium
for the times indicated At each chase time, cells were lysed and CD63
molecules immunoprecipitated from the detergent lysates followed
by analysis by SDS/PAGE, fluorography and autoradiography.
Trang 6in MHC class II compartments from a characteristic
multivesicular/multilaminar appearance to structures with
dense lipid moieties
CD63 is generally considered as one of the best markers of
MHC class II compartments besides MHC class II
mole-cules themselves [45,46] CD63 is a member of the tetraspanin
superfamily, consisting of polypeptides with four membrane
spanning domains that associate with a variety of proteins
[47] On the cell surface, tetraspanins were found to colocalize
in distinct membrane microdomains that are enriched for
specific MHC class II-peptide complexes as well as
costim-ulatory molecules, thereby facilitating T cell activation
[29,48,49] It has been shown recently that in human
immature dendritic cells and in B cells, CD63 and CD82
form complexes with MHC class II molecules in class II
compartments, whereas another set of tetraspanins
associ-ate with surface MHC class II molecules [28,29] Here, we
show that in both immature and mature dendritic cells, the
subcellular localization of CD63 molecules was confined to
the intracellular MHC class II compartment At later time
points of maturation, MHC class II synthesis and recycling
of MHC class II molecules from the cell surface is shut off
[10,17] In accordance with this, CD63 positive organelles in
mature dendritic cells were found to be depleted from
MHC class II molecules
CD63 has been localized to a wide variety of distinct
intracellular organelles whose content or membrane
mole-cules are discharged after appropriate stimuli These include
the cytolytic granules of cytotoxic T lymphocytes [50,51],
the Weibel–Palade bodies of vascular endothelial cells [52],
the secretory granules of neutrophils and basophils [53,54],
as well as those from megakaryocytes and platelets [55]
Interestingly, all of these organelles rely on stimulated
processes to release their content, a process that may be similar to the regulated redistribution of MHC class II molecules from the MHC class II compartment to the plasma membrane, as occurs during dendritic cell develop-ment [10] Indeed, dendritic cells secrete exosomes upon fusion of multivesicular organelles with the cell surface [21,23] Exosomes contain high levels of tetraspanins, including CD63, in agreement with the localization of CD63 to internal membranes of multivesicular bodies [40] Dendritic cells, however, contain mainly multilaminar MHC class II compartments and probably only a minor part of the MHC class II molecules are secreted in exosomes Recent data revealed an additional pathway of transport of MHC class II molecules to the cell surface, namely via tubules that emerge from MHC class II com-partment and fuse with the plasma membrane [24–26] CD63 was found to be absent from these tubules and remained associated with MHC class II compartments [26],
in agreement with our results Although we did not observe tubular structures in our immuno-electronmicroscopy stud-ies, both the described modification of CD63 (this study) and the previously reported appearance of tubules occurs 12–20 h after maturation [26] Whether there is a direct role for CD63 in the formation of tubules remains to be investigated
Maturation of dendritic cells resulted in an increase in the CD63 molecular mass by 20 kDa, that could be accoun-ted for by poly N-lactosaminoglycan addition This modi-fication differs from the usual complex-type N-linked saccharides and is characterized by having side chains of Galb1–4GlcNAcb1–3 repeats Poly N-lactosaminoglycans are present on several membrane proteins, including the lysosomal associated membrane proteins 1 and 2 (LAMP-1
Fig 5 Subcellular localization of CD63 and
LAMP molecules in immature and mature
dendritic cells Immature and mature dendritic
cells were labeled metabolically with
[35S]methionine/cysteine prior to
homogeni-zation and subcellular fractionation by
organelle electrophoresis After
electropho-resis, fractions were pooled as indicated in A,
lysed and CD63 or LAMP molecules
immunoprecipitated and analyzed by
SDS/PAGE Shown are autoradiographs
after fluorography (B).
Trang 7and LAMP-2 [42,43]), but the physiological significance of
this post-translational modification has remained unclear
In human dendritic cells, LAMP also acquired additional
lactosaminoglycans upon dendritic cell maturation (this
study), with similar kinetics as CD63, whereas cell-surface
localized tetraspanins were not modified (not shown) It will
be interesting to analyze the post-translational
modifica-tions on the dendritic cell-specific lysosomal protein
DC-LAMP during dendritic cell maturation, since this protein
was found to colocalize with MHC class II in tubules in
contrast to LAMP and CD63 [26]
One possible function of the extensive glycosylation of
lysosomal membrane proteins is to protect the lysosomes as
well as lysosome-like organelles from excessive degradative
activities The changes observed in MHC class II
compart-ments from multilaminar organelles to vesicles with densely
packed membranes might be accompanied with changes in
the function of these organelles In mature dendritic cells,
macropinocytosis has ceased, but receptor-mediated
endo-cytosis is still ongoing, although it is unclear if internalized
antigens can reach degradative organelles Interestingly,
preliminary studies revealed reduction in the activity of the lysosomal enzyme b-hexosaminidase in MHC class II com-partments, in accordance with the previously reported disappearance of acidic organelles during dendritic cell maturation [56]
Neither the stability nor the subcellular localization of CD63 molecules was altered upon the addition of poly N-lactosaminoglycans during dendritic cell maturation However, the extensive poly N-lactosaminoglycan addition
on CD63 molecules during dendritic cell development, may
be functionally important to maintain the endo–lysosomal system during dendritic cell development and accompanies the dramatic change in lysosomal morphology (see Fig 6) Although post-translational modification could occur as a result from the morphological changes observed upon dendritic cell maturation, the addition of lactosamino-glycans on CD63 molecules could be involved in the modulation of class II peptide loading events, possibly through contributing to a differential distribution of associated MHC class II molecules during maturation of dendritic cells
Fig 6 Distribution of CD63 and MHC class II molecules in immature and mature dendritic cells by immunocytochemistry (A) Immature (a) and mature (b–d) dendritic cells were fixed and embedded as described in Materials and methods Ultrathin cryosections were labeled with anti-CD63 and anti-MHC class II Igs, followed by 10 nm and 15 nm protein A-gold, respectively (a–c) Detail of intracellular organelles, (d) overview Bar,
50 nm (B) Morphology of MHC class II-containing organelles in immature and mature dendritic cells analyzed by immunocytochemistry Immature (a) and mature (b–d) dendritic cells were fixed and embedded and ultrathin cryosections were labeled with anti-MHC class II Igs, followed by 15 nm protein A-gold Bar, 50 nm.
Trang 8We thank M Cella and A Lanzavecchia for discussion and critical
review of the manuscript, S Paniry for photography and H L Ploegh
for antibodies The Basel Institute for Immunology was founded and
supported by F Hoffmann-La Roche & Co., Ltd, Basel, Switzerland.
This work was supported in part by the Swiss National Science
Foundation.
References
1 Lanzavecchia, A & Sallusto, F (2001) Regulation of T cell
immunity by dendritic cells Cell 106, 263–266.
2 Cella, M., Sallusto, F & Lanzavecchia, A (1997) Origin,
maturation and antigen presenting function of dendritic cells.
Curr Opin Immunol 9, 10–16.
3 Pieters, J (2000) MHC Class II restricted antigen processing and
presentation Adv Immunol 75, 159–200.
4 Engering, A.J., Cella, M., Fluitsma, D.M., Hoefsmit, E.C.M.,
Lanzavecchia, A & Pieters, J (1997) The mannose receptor
functions as a high capacity and broad specificity antigen receptor
in human dendritic cells Eur J Immunol 27, 2417–2425.
5 Watts, C (1997) Capture and processing of exogenous antigens
for presentation on MHC molecules Annu Rev Immunol 15,
821–850.
6 Amigorena, S., Drake, J.R., Webster, P & Mellman, I (1994)
Transient accumulation of new MHC molecules in a novel
endocytic compartment in B lymphocytes Nature 369, 113–120.
7 Tulp, A., Verwoerd, D., Dobberstein, B., Ploegh, H.L & Pieters,
J (1994) Isolation and characterization of the intracellular MHC
class II compartment Nature 369, 120–126.
8 West, M.A., Lucocq, J.M & Watts, C (1994) Antigen processing
and class II MHC peptide-loading compartments in human
B-lymphoblastoid cells Nature 369, 147–151.
9 Ferrari, G., Knight, A.M., Watts, C & Pieters, J (1997)
Distinct intracellular compartments involved in invariant chain
degradation and antigenic peptide loading of major
histo-compatibility complex (MHC) class II molecules J Cell Biol 139,
1433–1446.
10 Cella, M., Engering, A., Pinet, V., Pieters, J & Lanzavecchia, A.
(1997) Inflammatory stimuli induce accumulation of MHC class II
complexes on dendritic cells Nature 388, 782–787.
11 Pierre, P., Turley, S.J., Gatti, E., Hull, M., Meltzer, J., Mirza, A.,
Inaba, K., Steinman, R.M & Mellman, I (1997) Developmental
regulation of MHC class II transport in mouse dendritic cells.
Nature 388, 787–792.
12 Driessen, C., Bryant, R.A., Lennon-Dumenil, A.M., Villadangos,
J.A., Bryant, P.W., Shi, G.P., Chapman, H.A & Ploegh, H.L.
(1999) Cathepsin S controls the trafficking and maturation of
MHC class II molecules in dendritic cells J Cell Biol 147,
775–790.
13 Pierre, P & Mellman, I (1998) Developmental regulation of
invariant chain proteolysis controls MHC class II trafficking in
mouse dendritic cells Cell 93, 1135–1145.
14 Bakke, O & Dobberstein, B (1990) MHC class II-associated
invariant chain contains a sorting signal for endosomal
compart-ments Cell 63, 707–716.
15 Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L.,
Schmid, S.L., Quaranta, V & Peterson, P.A (1990) Intracellular
transport of class II MHC molecules directed by invariant chain.
Nature 348, 600–605.
16 Pieters, J., Bakke, O & Dobberstein, B (1993) The MHC class
II-associated Invariant chain contains two endosomal sorting signals
within its cytoplasmic tail J Cell Sci 106, 831–846.
17 Villadangos, J.A., Cardoso, M., Steptoe, R.J., van Berkel, D.,
Pooley, J., Carbone, F.R & Shortman, K (2001) MHC class II
18 Banchereau, J & Steinman, R.M (1998) Dendritic cells and the control of immunity Nature 392, 245–252.
19 Hiltbold, E.M & Roche, P.A (2002) Trafficking of MHC class II molecules in the late secretory pathway Curr Opin Immunol 14, 30–35.
20 Yewdell, J.W & Tscharke, D.C (2002) Inside the professionals Nature 418, 923–924.
21 Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G & Amigorena, S (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes Nat Med 4, 594– 600.
22 Raposo, G., Nijman, H.W., Stoorvogel, W., Leijendekker, R., Harding, C.V., Melief, C.J.M & Geuze, H.J (1996) B lympho-cytes secrete antigen-presenting vesicles J Exp Med 183, 1161–1172.
23 Thery, C., Regnault, A., Garin, J., Wolfers, J., Zitvogel, L., Ricciardi-Castagnoli, P., Raposo, G & Amigorena, S (1999) Molecular characterization of dendritic cell-derived exosomes Selective accumulation of the heat shock protein hsc73 J Cell Biol 147, 599–610.
24 Boes, M., Cerny, J., Massol, R., Op den Brouw, M., Kirchhausen, T., Chen, J & Ploegh, H.L (2002) T-cell engagement of dendritic cells rapidly rearranges MHC class II transport Nature 418, 983–988.
25 Chow, A., Toomre, D , Garrett, W & Mellman, I (2002) D en-dritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane Nature 418, 988–994.
26 Barois, N., De Saint-Vis, B., Lebecque, S., Geuze, H.J & Kleijmeer, M.J (2002) MHC class II compartments in human dendritic cells undergo profound structural changes upon activa-tion Traffic 3, 894–905.
27 Kleijmeer, M., Ramm, G., Schuurhuis, D., Griffith, J., Rescigno, M., Ricciardi-Castagnoli, P., Rudensky, A.Y., Ossendorp, F., Melief, C.J., Stoorvogel, W & Geuze, H.J (2001) Reorganization
of multivesicular bodies regulates MHC class II antigen pre-sentation by dendritic cells J Cell Biol 155, 53–63.
28 Engering, A & Pieters, J (2001) Association of distinct tetra-spanins with MHC class II molecules at different subcellular locations in human immature dendritic cells Int Immunol 13, 127–134.
29 Hammond, C., Denzin, L.K., Pan, M., Griffith, J.M., Geuze, H.J.
& Cresswell, P (1998) The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with
HLA-DR-DM, and -DO molecules J Immunol 161, 3282–3291.
30 Sallusto, F & Lanzavecchia, A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleu-kin 4 and downregulated by tumor necrosis factor alpha J Exp Med 179, 1109–1118.
31 Johnson, J.P., Demmer-Dieckmann, M., Meo, T., Hadam, M.R.
& Riethmuller, G (1981) Surface antigens of human melanoma cells defined by monoclonal antibodies I Biochemical character-ization of two antigens found on cell lines and fresh tumors of diverse tissue origin Eur J Immunol 11, 825–831.
32 Pieters, J., Horstmann, H., Bakke, O., Griffiths, G & Lipp, J (1991) Intracellular transport and localization of major histo-compatibility complex class II molecules and associated invariant chain J Cell Biol 115, 1213–1223.
33 Engering, A.J., Richters, C.D., Fluitsma, D.M., van Pelt, A.M., Kamperdijk, E.W., Hoefsmit, E.C & Pieters, J (1998) MHC class
II and invariant chain biosynthesis and transport during maturation of human precursor dendritic cells Int Immunol 10, 1713–1723.
Trang 934 Laemmli, U.K (1970) Cleavage of structural proteins during the
assembly of the head of bacteriophage T4 Nature 227, 680–685.
35 O’Farrell, P.H (1975) High resolution two-dimensional
electro-phoresis of proteins J Biol Chem 250, 4007–4021.
36 Lefkovits, I., Young, P., Kuhn, L., Kettman, J., Gemmell, A.,
Tollaksen, S., Anderson, L & Anderson, N (1985) Use of
Large-Scale Two-Dimensional ISODALT Gel Electrophoresis Systems in
Immunology Academic Press, Orlando, FL.
37 Tulp, A., Verwoerd, D & Pieters, J (1993) Application of an
improved density gradient electrophoresis apparatus to the
separation of proteins, cells and subcellular organelles
Electro-phoresis 14, 1295–1301.
38 Bradford, M (1976) A rapid and sensitive method for the
quan-titation of microgram quantities of protein utilizing the principle
of protein-dye binding Anal Biochem 72, 248–254.
39 Koldovsky, O & Palmieri, M (1971) Cortisone-evoked decrease
of acid b-galactosidase, b-glucuronidase,
N-acetyl-b-glucosamini-dase and acrylsulphatase in the ileum of sucling rats Biochem.
J 125, 697–701.
40 Escola, J.M., Kleijmeer, M.J., Stoorvogel, W., Griffith, J.M.,
Yoshie, O & Geuze, H.J (1998) Selective enrichment of tetraspan
proteins on the internal vesicles of multivesicular endosomes and
on exosomes secreted by human B-lymphocytes J Biol Chem.
273, 20121–20127.
41 Metzelaar, M.J., Wijngaard, P.L., Peters, P.J., Sixma, J.J.,
Nieu-wenhuis, H.K & Clevers, H.C (1991) CD63 antigen A novel
lysosomal membrane glycoprotein, cloned by a screening
proce-dure for intracellular antigens in eukaryotic cells J Biol Chem.
266, 3239–3245.
42 Carlsson, S.R & Fukuda, M (1990) The polylactosaminoglycans
of human lysosomal membrane glycoproteins lamp-1 and lamp-2.
Localization on the peptide backbones J Biol Chem 265,
20488–20495.
43 Lee, N., Wang, W.C & Fukuda, M (1990) Granulocytic
differ-entiation of HL-60 cells is associated with increase of
poly-N-acetyllactosamine in Asn-linked oligosaccharides attached to
human lysosomal membrane glycoproteins J Biol Chem 265,
20476–20487.
44 Sallusto, F., Cella, M., Danieli, C & Lanzavecchia, A (1995)
Dendritic cells use macropinocytosis and the mannose receptor to
concentrate macromolecules in the major histocompatibility
complex class II compartment: downregulation by cytokines and
bacterial products J Exp Med 182, 389–400.
45 Hunziker, W & Geuze, H.J (1996) Intracellular trafficking of lysosomal membrane proteins Bioessays 18, 379–389.
46 Kleijmeer, M.J., Raposo, G & Geuze, H.J (1996) Characteriza-tion of MHC Class II Compartments by Immunoelectron Microscopy Methods 10, 191–207.
47 Maecker, H.T., Todd, S.C & Levy, S (1997) The tetraspanin superfamily: molecular facilitators FASEB J 11, 428–442.
48 Kropshofer, H., Spindeldreher, S., Rohn, T.A., Platania, N., Grygar, C., Daniel, N., Wolpl, A., Langen, H., Horejsi, V & Vogt, A.B (2002) Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes Nat Immunol 3, 61–68.
49 Vogt, A.B., Spindeldreher, S & Kropshofer, H (2002) Clustering
of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains Immunol Rev 189, 136–151.
50 Peters, P.J., Borst, J., Oorschot, V., Fukuda, M., Krahenbuhl, O., Tschopp, J., Slot, J.W & Geuze, H.J (1991) Cytotoxic T lym-phocyte granules are secretory lysosomes, containing both per-forin and granzymes J Exp Med 173, 1099–1109.
51 Griffiths, G.M (1995) The cell biology of CTL killing, Curr Opin Immunol 7, 343–348.
52 Vischer, U.M & Wagner, D.D (1993) CD63 is a component
of Weibel-Palade bodies of human endothelial cells Blood 82, 1184–1191.
53 Tapper, H & Grinstein, S (1997) Fc receptor-triggered insertion
of secretory granules into the plasma membrane of human neu-trophils: selective retrieval during phagocytosis J Immunol 159, 409–418.
54 Calafat, J., Janssen, H., Knol, E.F., Weller, P.F & Egesten, A (1997) Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils Eur J Haematol 58, 56–66.
55 Heijnen, H.F., Debili, N., Vainchencker, W., Breton-Gorius, J., Geuze, H.J & Sixma, J.J (1998) Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules Blood 91, 2313–2325.
56 Stossel, H., Koch, F., Kampgen, E., Stoger, P., Lenz, A., Heufler, C., Romani, N & Schuler, G (1990) Disappearance
of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells J Exp Med 172, 1471– 1482.